ISSN: 1875-6921

Journal Home

Journal Guideline

Current Pharmacogenomics and Personalized Medicine Q4 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Pharmacogenomics and Personalized Medicine is a journal indexed in SJR in Molecular Biology and Genetics with an H index of 20. It has an SJR impact factor of 0,127 and it has a best quartile of Q4. It has an SJR impact factor of 0,127.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Genetics (Q4) Genetics (clinical) (Q4) Genetics (clinical) (Q4) Molecular Biology (Q4) Molecular Medicine (Q4) Pharmacology (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Current Pharmacogenomics and Personalized Medicine

0,127

SJR Impact factor

20

H Index

12

Total Docs (Last Year)

49

Total Docs (3 years)

613

Total Refs

9

Total Cites (3 years)

42

Citable Docs (3 years)

0.08

Cites/Doc (2 years)

51.08

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cytogenetic and Genome Research Q4
Journal of Biomolecular Techniques Q4
Journal of Molecular Recognition Q4
Gene Expression Patterns Q4
Molecular Biology Research Communications Q4

Compare this journals

Aims and Scope

Best articles by citations

Understanding Heterogeneity in Supplementation Effects of Selenium in Men: A Study of Stratification Variables and Human Genetics in a Prospective Sample from New Zealand

Meet Our Editorial Board Member

Lanthenide-Doped Nanophosphor labels for Protein Microarrays

Nanotechniques and Proteomics: An Integrated Platform for Diagnostics,Targeted Therapeutics and Personalized Medicine

Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine

Meet Our Editorial Board Member

Proteomics Studies in Oncology Towards Personalized Medicine in Public Health: Opportunities and Challenges for OMICS Research in Iran

Translating Pharmacogenetics and Pharmacogenomics: The Last 60 Years and the Rise of Collective Innovation as a Force Multiplier for Personalized Medicine

Non-B DNA Structures as Candidate Drug Targets Against Structural Chromosomal Instability

A Broader Perspective on Personalized Medicine: Lessons from Discourse Analysis and Knowledge Translation

Genetic Polymorphisms in the Growth Hormone Receptor: Impact on Growth Response and Disease Susceptibility

Meet Our Editorial Board Member

SHOW MORE ARTICLES

Metabolomics-based Approach to Pharmacotherapy Personalization: Advantages and Limitations

Gene-Gene Interactions in a Context of Individual Variability in Antipsychotic Drug Pharmacogenomics

Genetic Polymorphisms of CYP2D6: Prevalence in Healthy Kurds

Not So Simple: Situating Postgenomics Personalized Medicine in the Regional Context in Africa for Global and Womens Health

Differences in MDR1 (C3435T), CYP2D6, and CYP1A2 Genotype Frequencies between Patients with Treatment Failure to Antipsychotics and Healthy Russian Population

Eating Disorder Symptoms and CYP2D6 Variation in Cuban Healthy Females: A Report from the Ibero-American Network of Pharmacogenetics

Nutraceutical: A Drug, Dietary Supplement and Food Ingredient

Health Economic Modelling in Stratified Medicine - Example Depression

Pharmacoproteomics Applications for Drug Target Discovery in CNS Disorders

Reporting and Interpretation of the CYP2C19 Genotyping Test for Clopidogrel Dosing

Drug Abuse Treatment through Gene Manipulation Using Nanomedicine

Rethinking Pharmacogenomics Education Beyond Health Professionals: Addressing the “Know-Do” Gap Across the Personalized Medicine Innovation Ecosystem

Current Pharmacogenomics and Personalized Medicine Q4 Unclaimed

- €

NPD

- €

Metrics

0,127

20

12

49

613

9

42

0.08

51.08

Comments

Other journals with similar parameters

Aims and Scope

Best articles by citations

FAQS

What is the impact factor of Current Pharmacogenomics and Personalized Medicine?